LFVN250117C5000
- 0.00
- 0.000.00%
Lifevantage Newsroom
Lake Street Maintains Lifevantage(LFVN.US) With Buy Rating, Maintains Target Price $26
Lake Street Initiates Lifevantage(LFVN.US) With Buy Rating, Announces Target Price $26
Top 3 Risk Off Stocks That May Collapse This Month
Are Investors Undervaluing LifeVantage Corporation (NASDAQ:LFVN) By 41%?
LifeVantage Corporation (NASDAQ:LFVN) Stocks Shoot Up 31% But Its P/E Still Looks Reasonable
Lake Street Initiates Coverage On Lifevantage With Buy Rating, Announces Price Target of $26
Lifevantage Analyst Ratings
"Weight-Loss Drug Craze Appears To Be Curbing U.S. Obesity Epidemic; Obesity Is Down In The U.S. For The First Time In A Decade. A New Study Suggests Weight-Loss Drugs May Explain Why" - Bloomberg News
'ADA Advises Against Using Compounded GLP-1 RA Medications' - Medscape
LifeVantage to Participate in the Water Tower Fireside Chat Series
LifeVantage Unveils Lip Care Favorite Back for Cyber Monday
Returns On Capital Signal Tricky Times Ahead For LifeVantage (NASDAQ:LFVN)
LifeVantage's (NASDAQ:LFVN) Dividend Will Be $0.04
Here's Why We Think LifeVantage Corporation's (NASDAQ:LFVN) CEO Compensation Looks Fair
Lifevantage To Go Ex-Dividend On December 2nd, 2024 With 0.04 USD Dividend Per Share
October 30th (Eastern Time) - $Lifevantage(LFVN.US)$ is trading ex-dividend on December 2nd, 2024.Shareholders of record on December 2nd, 2024 will receive 0.04 USD dividend per share on December 16
Lifevantage Shares Are Trading Lower After the Company Reported Worse-than-expected Q1 Revenue Results.
LifeVantage Maintains Dividend at $0.04 per Share, Payable Dec. 16 to Shareholders of Record on Dec. 2
LifeVantage Corporation (LFVN) Q1 2025 Earnings Call Transcript Summary
LifeVantage Corporation (LFVN) Q1 2025 Earnings Call Transcript
Lifevantage: Fiscal Q1 Earnings Snapshot